Drug manufacturer AbbVie recently replied to Louisiana’s request for summary judgement and defended its own such request in its ongoing [...] …
Category: State
Despite its overwhelming support from the state legislature, Virginia Gov. Glenn Youngkin (R) late yesterday amended a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
South Carolina last week became the twenty-third state to introduce a bill this legislative session to bar drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district court has transferred drugmaker AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law to a judge who [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmacy benefit managers (PBMs) and insurers operating in Oregon are barred from restricting 340B drug dispensing or limiting the number [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Maryland and Kansas legislatures have each cleared bills that would prohibit drug manufacturer 340B contract pharmacy restrictions in their [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Mississippi state senate yesterday overwhelmingly cleared for the governor’s consideration a bill to prohibit drugmaker 340B contract pharmacy restrictions, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Sexually transmitted disease (STD) clinics in Tennessee may soon have to enter into contracts to receive 340B in-kind funding—and for-profit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Bristol Myers Squibb (BMS), Amgen, and Bayer became the latest drugmakers to formally exempt Arkansas providers from their 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese drugmaker Astellas will soon extend its limits on 340B pricing to hospitals for its medication to treat overreactive bladder, [...] …